485.57USD-3.24%Mkt Cap: 11.18B USDP/E: —Last update: 2026-06-01
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directe…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap11.18B USD
Enterprise Value11.00B USD
Revenue (TTM)1.13B USD
Gross Profit902.25M USD
Net Income (TTM)-288.28M USD
Revenue/Share49.95 USD
Last Price485.57 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees915
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5588681057
Valuation
P/E (Trailing)—
P/E (Forward)40.17
PEG—
EV/EBITDA-35.26
EV/Revenue9.71
P/S10.12
P/B21.08
EPS (TTM)-13.48
EPS (Forward)12.38
52W Range
265.2063% of range615.00
52W High615.00 USD
52W Low265.20 USD
Profitability
Gross Margin94.14%
Oper. Margin-29.78%
EBITDA Margin-27.55%
Profit Margin-30.08%
ROE-47.83%
ROA-22.89%
Growth
Revenue Growth126.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-189.55M USD
CapEx (TTM)3.47M USD
FCF Margin-13.81%
FCF Yield-1.40%
Net Debt-465.46M USD
Net Debt/EBITDA1.49
Balance Sheet
Debt/Equity0.58
Current Ratio3.50
Quick Ratio2.96
Book Value/Sh23.59 USD
Cash/Share35.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 25, 2016
Splits
Last Split1:35
Split DateJul 25, 2016
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)679.29 USD
Target Range550.00 USD – 964.00 USD
# Analysts14
Ownership
Shares Out.23.06M
Float12.91M
Insiders5.68%
Institutions106.22%
Short Interest
Short Ratio14.1d
Short % Float19.88%
Short % Out.16.90%
Shares Short3.90M
Short (prev mo.)4.01M
Technical
SMA 50512.12 (-5.2%)
SMA 200487.16 (-0.3%)
Beta-1.04
S&P 52W Chg27.94%
Avg Vol (30d)254.90K
Avg Vol (10d)259.53K
Technical Indicators
RSI (14)43.8
MACD1.2964
MACD Signal2.6844
MACD Hist.-1.3880
BB Upper542.34 USD
BB Middle518.52 USD
BB Lower494.70 USD
BB Width9.19%
ATR (14)21.09 USD
Vol Ratio (20d)1.00x